Homepage
Open in app
Sign in
Get started
Variant Bio
About Us
All Posts
Tagged in
Lux Capital
Variant Bio
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
More information
Followers
133
Elsewhere
More, on Medium
Lux Capital
Andrew Farnum
in
Variant Bio
Aug 12, 2020
Variant Bio Finalizes Series A Financing
Investors include Lux Capital, Alta Partners, Casdin Capital…
Read more…
53
Sarah LeBaron von Baeyer, PhD
in
Variant Bio
May 28, 2020
Bloomberg Businessweek Shines a Light on the Work of Variant Bio
Read more…
3